Cargando…
Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis
BACKGROUND: Breast cancer is one of the most common and malignant tumors in the world. Nowadays more attention has been garnered in pristimerin anti-cancer effects. Here, we illustrate the function and regulatory mechanism of pristimerin in breast cancer therapy. MATERIALS AND METHODS: Breast cancer...
Autores principales: | Cheng, Shihuan, Zhang, Zhihong, Hu, Cong, Xing, Na, Xia, Yan, Pang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354954/ https://www.ncbi.nlm.nih.gov/pubmed/32753899 http://dx.doi.org/10.2147/OTT.S257329 |
Ejemplares similares
-
Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis
por: Shu, Chang, et al.
Publicado: (2020) -
Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p
por: Li, Zaiyu, et al.
Publicado: (2019) -
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
por: Unterbruner, Kristoffer, et al.
Publicado: (2018) -
Mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction
por: Cai, Guofeng, et al.
Publicado: (2021) -
Micro-RNA miR-542-3p suppresses decidualization by targeting ILK pathways in human endometrial stromal cells
por: Qu, Xinlan, et al.
Publicado: (2021)